vs
Aveanna Healthcare Holdings, Inc.（AVAH）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是Aveanna Healthcare Holdings, Inc.的1.5倍（$906.4M vs $621.9M），Rollins, Inc.净利率更高（11.9% vs 2.3%，领先9.6%），Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 10.2%），过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 0.8%）
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
AVAH vs ROL — 直观对比
营收规模更大
ROL
是对方的1.5倍
$621.9M
营收增速更快
AVAH
高出12.0%
10.2%
净利率更高
ROL
高出9.6%
2.3%
两年增速更快
AVAH
近两年复合增速
0.8%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $621.9M | $906.4M |
| 净利润 | $14.1M | $107.8M |
| 毛利率 | 32.6% | — |
| 营业利润率 | 8.6% | 16.1% |
| 净利率 | 2.3% | 11.9% |
| 营收同比 | 22.2% | 10.2% |
| 净利润同比 | 132.8% | 2.5% |
| 每股收益（稀释后） | $0.06 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAHROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | — | $912.9M | ||
| Q3 25 | $621.9M | $1.0B | ||
| Q2 25 | $589.6M | $999.5M | ||
| Q1 25 | $559.2M | $822.5M | ||
| Q4 24 | $519.9M | $832.2M | ||
| Q3 24 | $509.0M | $916.3M | ||
| Q2 24 | $505.0M | $891.9M |
净利润AVAHROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | — | $116.4M | ||
| Q3 25 | $14.1M | $163.5M | ||
| Q2 25 | $27.0M | $141.5M | ||
| Q1 25 | $5.2M | $105.2M | ||
| Q4 24 | $29.2M | $105.7M | ||
| Q3 24 | $-42.8M | $136.9M | ||
| Q2 24 | $13.9M | $129.4M |
毛利率AVAHROL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 32.6% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 33.0% | — | ||
| Q3 24 | 31.4% | — | ||
| Q2 24 | 31.3% | — |
营业利润率AVAHROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | — | 17.5% | ||
| Q3 25 | 8.6% | 21.9% | ||
| Q2 25 | 13.6% | 19.8% | ||
| Q1 25 | 9.3% | 17.3% | ||
| Q4 24 | 8.8% | 18.1% | ||
| Q3 24 | 6.7% | 20.9% | ||
| Q2 24 | 7.4% | 20.4% |
净利率AVAHROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | — | 12.8% | ||
| Q3 25 | 2.3% | 15.9% | ||
| Q2 25 | 4.6% | 14.2% | ||
| Q1 25 | 0.9% | 12.8% | ||
| Q4 24 | 5.6% | 12.7% | ||
| Q3 24 | -8.4% | 14.9% | ||
| Q2 24 | 2.8% | 14.5% |
每股收益（稀释后）AVAHROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.06 | $0.34 | ||
| Q2 25 | $0.13 | $0.29 | ||
| Q1 25 | $0.03 | $0.22 | ||
| Q4 24 | $0.15 | $0.22 | ||
| Q3 24 | $-0.22 | $0.28 | ||
| Q2 24 | $0.07 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.9M | $116.5M |
| 总债务越低越好 | $1.3B | $650.6M |
| 股东权益账面价值 | $9.2M | $1.4B |
| 总资产 | $1.8B | $3.2B |
| 负债/权益比越低杠杆越低 | 141.83× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资AVAHROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | — | $100.0M | ||
| Q3 25 | $145.9M | $127.4M | ||
| Q2 25 | $100.7M | $123.0M | ||
| Q1 25 | $71.5M | $201.2M | ||
| Q4 24 | $84.3M | $89.6M | ||
| Q3 24 | $78.5M | $95.3M | ||
| Q2 24 | $47.7M | $106.7M |
总债务AVAHROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | $1.3B | $485.7M | ||
| Q2 25 | $1.3B | $485.3M | ||
| Q1 25 | $1.3B | $485.5M | ||
| Q4 24 | $1.3B | $395.3M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
股东权益AVAHROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $9.2M | $1.5B | ||
| Q2 25 | $-12.0M | $1.4B | ||
| Q1 25 | $-100.1M | $1.4B | ||
| Q4 24 | $-123.6M | $1.3B | ||
| Q3 24 | $-156.4M | $1.3B | ||
| Q2 24 | $-119.0M | $1.2B |
总资产AVAHROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | $1.8B | $3.2B | ||
| Q2 25 | $1.8B | $3.2B | ||
| Q1 25 | $1.7B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.7B | $2.8B |
负债/权益比AVAHROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | 141.83× | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.2M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | 2.36× | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流AVAHROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | — | $164.7M | ||
| Q3 25 | $33.2M | $191.3M | ||
| Q2 25 | $51.6M | $175.1M | ||
| Q1 25 | $-8.6M | $146.9M | ||
| Q4 24 | $13.4M | $188.2M | ||
| Q3 24 | $29.4M | $146.9M | ||
| Q2 24 | $1.8M | $145.1M |
自由现金流AVAHROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $168.0M | ||
| Q1 25 | — | $140.1M | ||
| Q4 24 | — | $184.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率AVAHROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 17.8% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度AVAHROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率AVAHROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | 2.36× | 1.17× | ||
| Q2 25 | 1.91× | 1.24× | ||
| Q1 25 | -1.66× | 1.40× | ||
| Q4 24 | 0.46× | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | 0.13× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
ROL
暂无分部数据
